Nature of change: Retirement of Non-Executive Chairman and Non-Independent Director
Name and DIN: Mr. Berjis Desai (DIN: 00153675)
Effective date: September 21, 2026 (upon conclusion of the 20th Annual General Meeting)
Reason: Expressed unwillingness to seek reappointment due to appointment as Member of National Commission for Minorities, Government of India, New Delhi
The retirement is by rotation at the ensuing 20th Annual General Meeting
Mr. Desai will cease to be Director and Non-Executive Chairman upon conclusion of the 20th AGM
Designation of New Chairman
Nature of change: Designation of Mr. Clarence Carleton King II as Non-Executive Chairman and Independent Director
Name and DIN: Mr. Clarence Carleton King II (DIN: 08171208)
Effective date: September 21, 2026 (upon conclusion of the 20th Annual General Meeting)
Brief profile: Senior health care executive with 40 years of diverse experience. Expertise in health care financing and delivery. Has run hospitals, clinics, ambulatory surgery centers, HMOs, PPOs and managed care plans. Worked for publicly traded, privately held and provider-sponsored companies. Has managed organizations with profit and loss responsibility ranging from few million dollars to over nine billion dollars annually. Certified Corporate Director by National Association of Corporate Directors and Indian Institute of Corporate Affairs. Serves as expert witness in health care cases and currently chairing an arbitration panel in large health care dispute resolution case.
Relationship with other directors: None disclosed
Key Financial or Operational Approvals
No financial or operational approvals mentioned in this disclosure
Strategic or Business Context
No strategic or business context commentary provided in this disclosure
Any Other Material Information
Board meeting held on August 5, 2026 from 07:15 P.M. IST to 08:44 P.M. IST
Disclosure made under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Reference to SEBI Circular No. HO/49/14/14(7)2025-CFDPOD2/I/3762/2026 dated January 30, 2026 (Master Circular for compliance)
Information available on company website: https://ikshealth.com/investor-relations/
Signed by Sameer S Chavan, Company Secretary and Compliance Officer (Membership No. F7211)
